Meanwhile, we confirmed that the expression of TRIM25 in breast cancer patients was significantly upregulated, and its expression level positively correlated with clinical stages and poor prognosis of BC patients, indicating that TRIM25 is a potential oncogene in breast cancer. Here, TRIM25 is linked to breast carcinoma.